LBA-003Phase 1b/II study of cancer stemness inhibitor napabucasin in combination with FOLFIRI +/− bevacizumab (bev) in metastatic colorectal cancer (mCRC) patients (pts)
Bendell, J, Hubbard, J, O’Neil, BH, Jonker, D, Starodub, A, Peyton, J, Pitot, H, Halfdanarson, T, Nadeau, B, Zubkus, J, Adesunloye, B, Edenfield, J, Li, YZ, Li, W, Grothey, A, Borodyansky, L, Li, CJVolume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx302.002
Date:
June, 2017
File:
PDF, 98 KB
english, 2017